ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,689Medicare Part D Prescriptions Filled, Including Refills

Rank: 126 out of 2604

$732K Total Retail Price of All Prescriptions

Rank: 64 out of 2604

477 Patients Receiving at Least One Drug in Part D
31%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 477 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

26% of this provider’s 477 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 3,329 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 596 185 S3 1 1
LISINOPRIL 350 105 2 3
OMEPRAZOLE 334 108 3 5
SIMVASTATIN 293 117 4 2
TRAMADOL HCL 252 106 5 15
GABAPENTIN 243 95 6 12
LEVOTHYROXINE SODIUM 199 55 7 4
PROAIR HFA 170 45 8 27
FUROSEMIDE 170 78 8 8
RANITIDINE HCL 149 49 10 25
METFORMIN HCL 145 45 11 7
POTASSIUM CHLORIDE 135 55 12 16
CYCLOBENZAPRINE HCL 132 17 R 13 43
CYMBALTA 117 21 14 44
WARFARIN SODIUM 116 31 15 13
SPIRIVA 114 36 16 45
HYDROCHLOROTHIAZIDE 110 35 17 10
PRAVASTATIN SODIUM 110 59 17 14
METOPROLOL TARTRATE 106 60 19 9
NIASPAN 106 32 19 170
ATORVASTATIN CALCIUM 106 37 19 19
LANTUS 103 66 22 40
ATENOLOL 95 62 23 11
ADVAIR DISKUS 94 22 24 41
VENTOLIN HFA 90 19 25 63
FLUTICASONE PROPIONATE 88 27 26 31
FENOFIBRATE 85 24 27 69
PROMETHAZINE HCL 85 25 R 27 88
MORPHINE SULFATE ER 83 0 S2 29 58
IBUPROFEN 80 23 30 32
SERTRALINE HCL 79 35 31 23
SYMBICORT 79 26 31 105
INSULIN SYRINGE 79 44 31 109
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 21 34 22
ACETAMINOPHEN-CODEINE 72 28 S3 35 60
METHADONE HCL 72 0 S2 35 67
MELOXICAM 71 11 37 36
TRIAMTERENE-HCTZ 69 24 38 55
LANTUS SOLOSTAR 69 20 38 84
HYDROXYZINE PAMOATE 63 0 R 40 293
NAPROXEN 62 0 41 76
NORTRIPTYLINE HCL 62 22 41 449
BACLOFEN 61 0 43 101
ZETIA 61 23 43 94
CITALOPRAM HBR 60 28 45 18
FLUOXETINE HCL 59 33 46 49
GLIMEPIRIDE 58 18 47 57
LYRICA 58 0 47 79
METHOCARBAMOL 57 0 R 49 153
PEN NEEDLE 57 21 49 145
OXYBUTYNIN CHLORIDE 55 40 51 92
LOVASTATIN 54 28 52 24
FAMOTIDINE 54 22 52 68
AMLODIPINE BESYLATE 53 28 54 6
NEXIUM 51 0 55 53
PROPRANOLOL HCL 50 31 56 154
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.